Home
Home

shingles

Synergy Acquires FV-100 from BMY

Synergy Acquires FV-100 from BMY
Yahoo/Zacks

Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company

Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company
Fierce Biotech

Glaxo, Xenoport's Drug Approved to Treat Shingles Pain

Glaxo, Xenoport's Drug Approved to Treat Shingles Pain
Minyanville

Merck's New Vaccine, Partnerships Will Drive Stock Higher

Merck's New Vaccine, Partnerships Will Drive Stock Higher
Seeking Alpha

With Zostavax supplies restored, Merck aims for revival

With Zostavax supplies restored, Merck aims for revival
Fierce Pharma

Ample Supplies of Shingles Vaccine Return

Ample Supplies of Shingles Vaccine Return
WSJ

Merck: High Upside Expected From Vaccine

Merck: High Upside Expected From Vaccine
Seeking Alpha

ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59

ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Yahoo/BusinessWire

FDA OKs shingle vaccine for those aged 50 to 59

FDA OKs shingle vaccine for those aged 50 to 59
Reuters

News

Depomed regains rights to Gralise from Abbott Labs
Yahoo/AP